232 related articles for article (PubMed ID: 23109455)
1. Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
Rodríguez B; Burguera J; Berenguer M
Ann Hepatol; 2012; 11(6):907-14. PubMed ID: 23109455
[TBL] [Abstract][Full Text] [Related]
2. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
3. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
4. Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease.
Panda K; Lal BB; Sood V; Khanna R; Alam S
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1017-1026. PubMed ID: 38695602
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
[TBL] [Abstract][Full Text] [Related]
7. Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Zhu XQ; Li LY; Yang WM; Wang Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32809015
[TBL] [Abstract][Full Text] [Related]
8. Zinc mono-therapy in pre-symptomatic Chinese children with Wilson disease: a single center, retrospective study.
Abuduxikuer K; Wang JS
PLoS One; 2014; 9(1):e86168. PubMed ID: 24475083
[TBL] [Abstract][Full Text] [Related]
9. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
10. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
Seessle J; Gotthardt DN; Schäfer M; Gohdes A; Pfeiffenberger J; Ferenci P; Stremmel W; Weiss KH
J Inherit Metab Dis; 2016 Jan; 39(1):125-30. PubMed ID: 26067812
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
12. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
Leung M; Wu Lanzafame J; Medici V
J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
[No Abstract] [Full Text] [Related]
13. Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc?
Ranucci G; Di Dato F; Leone F; Vajro P; Spagnuolo MI; Iorio R
J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):e72-e73. PubMed ID: 25341025
[No Abstract] [Full Text] [Related]
14. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
Bruha R; Marecek Z; Pospisilova L; Nevsimalova S; Vitek L; Martasek P; Nevoral J; Petrtyl J; Urbanek P; Jiraskova A; Ferenci P
Liver Int; 2011 Jan; 31(1):83-91. PubMed ID: 20958917
[TBL] [Abstract][Full Text] [Related]
15. Serum transaminases in children with Wilson's disease.
Iorio R; D'Ambrosi M; Marcellini M; Barbera C; Maggiore G; Zancan L; Giacchino R; Vajro P; Marazzi MG; Francavilla R; Michielutti F; Resti M; Frediani T; Pastore M; Mazzarella G; Fusco G; Cirillo F; Vegnente A;
J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):331-6. PubMed ID: 15448420
[TBL] [Abstract][Full Text] [Related]
16. Wilson disease: the diagnostic challenge and treatment outcomes in a series of 262 cases.
Deguti MM; Araujo FC; Terrabuio DRB; Araujo TF; Barbosa ER; Porta G; Cançado ELR
Arq Neuropsiquiatr; 2024 May; 82(5):1-9. PubMed ID: 38811021
[TBL] [Abstract][Full Text] [Related]
17. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
19. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
20. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
